Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.10
Bid: 40.72
Ask: 40.80
Change: -0.24 (-0.58%)
Spread: 0.08 (0.196%)
Open: 41.36
High: 41.40
Low: 40.40
Prev. Close: 41.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
5th Apr 20117:00 amRNSTrading Statement
1st Apr 20113:23 pmRNSChange of Address
28th Mar 20113:44 pmRNSAcquisition Update
16th Mar 20115:24 pmRNSDirector/PDMR Shareholding
7th Mar 20117:06 amRNSHolding(s) in Company
7th Mar 20117:00 amRNSReceipt of Assura monies and Special Interim Divi
24th Feb 20112:55 pmRNSHolding(s) in Company
23rd Feb 20114:14 pmRNSHolding(s) in Company
23rd Feb 20114:08 pmRNSHolding(s) in Company
23rd Feb 20114:04 pmRNSHolding(s) in Company
21st Feb 20112:24 pmRNSAdmission of ordinary shares
18th Feb 20113:31 pmRNSHolding(s) in Company
18th Feb 201111:35 amRNSHolding(s) in Company
18th Feb 201111:11 amRNSDirector/PDMR Shareholding
18th Feb 201110:39 amRNSRule 8 Announcement
18th Feb 201110:10 amRNSRule 8 Announcement
18th Feb 20117:00 amRNSAcquisition: First Closing Date
18th Feb 20117:00 amPRNFirst Closing Date: Offer Unconditional
17th Feb 20115:26 pmRNSRule 8 Announcement
17th Feb 20115:26 pmRNSRule 8 Announcement
17th Feb 20114:22 pmRNSHolding(s) in Company
17th Feb 20112:47 pmBUSForm 8.3 - ASSURA GROUP LTD
17th Feb 20112:21 pmBUSForm 8.3 - Assura Group Limited
17th Feb 201112:53 pmRNSEGM Results
17th Feb 201110:03 amRNSRule 2.10 Announcement
16th Feb 20117:00 amRNSResult of Open Offer
15th Feb 20113:32 pmPRNResult of EGM
10th Feb 20117:00 amRNSInterim Management Statement
27th Jan 20113:00 pmRNSPublication of Prospectus
27th Jan 20113:00 pmPRNPublication of Prospectus, Circular and Offer Document
21st Jan 20113:18 pmRNSHolding(s) in Company
20th Jan 20111:32 pmBUSForm 8.3 - Assura Group Limited
20th Jan 20111:00 pmBUSForm 8.3 - Assura Group Limited
19th Jan 20117:00 amRNSOffer for AH Medical Properties plc
19th Jan 20117:00 amPRNRecommended Offer by Assura Group for AH Medical
10th Jan 20114:40 pmRNSSecond Price Monitoring Extn
10th Jan 20114:35 pmRNSPrice Monitoring Extension
5th Jan 20113:22 pmBUSForm 8.3 - Assura Group Limited
24th Dec 201010:27 amRNSForm 8 (OPD) - Assura Group Limited
23rd Dec 20103:14 pmBUSForm 8.3 - Assura Group Limited
21st Dec 20102:59 pmRNSForm 8 (OPD) Assura Group Ltd
21st Dec 20101:30 pmBUSForm 8.3 - Assura Group Limited
16th Dec 201010:46 amRNSForm 8.3 - Assura Group Limited
14th Dec 20101:22 pmBUSForm 8.3 - Assura Group Limited
13th Dec 20101:44 pmBUSForm 8.3 - Assura Group Ltd
10th Dec 20102:43 pmRNSPotential Acquisition
23rd Nov 20107:00 amRNSHalf Yearly Report
12th Nov 20102:46 pmRNSNotification of Major Interest in Shares
28th Oct 20102:58 pmRNSNotice of Results
12th Oct 20104:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.